A detailed history of Jpmorgan Chase & CO transactions in Grifols Sa stock. As of the latest transaction made, Jpmorgan Chase & CO holds 2,002,511 shares of GRFS stock, worth $15.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,002,511
Previous 820,552 144.04%
Holding current value
$15.7 Million
Previous $5.17 Million 244.01%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$6.28 - $9.38 $7.42 Million - $11.1 Million
1,181,959 Added 144.04%
2,002,511 $17.8 Million
Q2 2024

Aug 12, 2024

SELL
$6.27 - $7.7 $1.45 Million - $1.78 Million
-231,723 Reduced 22.02%
820,552 $5.17 Million
Q1 2024

May 10, 2024

SELL
$5.47 - $11.38 $4.6 Million - $9.58 Million
-841,504 Reduced 44.44%
1,052,275 $7.03 Million
Q4 2023

Feb 12, 2024

BUY
$7.71 - $11.56 $4.05 Million - $6.07 Million
525,162 Added 38.37%
1,893,779 $21.9 Million
Q3 2023

Nov 14, 2023

BUY
$8.91 - $10.91 $2.93 Million - $3.59 Million
329,372 Added 31.69%
1,368,617 $12.5 Million
Q2 2023

Aug 11, 2023

SELL
$7.14 - $9.29 $6.31 Million - $8.21 Million
-884,256 Reduced 45.97%
1,039,245 $9.52 Million
Q1 2023

May 11, 2023

BUY
$6.65 - $10.69 $2.28 Million - $3.67 Million
342,912 Added 21.7%
1,923,501 $14.2 Million
Q4 2022

Feb 13, 2023

SELL
$5.96 - $8.53 $5.94 Million - $8.5 Million
-995,903 Reduced 38.65%
1,580,589 $13.4 Million
Q3 2022

Nov 14, 2022

SELL
$5.95 - $14.3 $3.14 Million - $7.54 Million
-527,393 Reduced 16.99%
2,576,492 $15.9 Million
Q2 2022

Aug 11, 2022

SELL
$10.6 - $13.28 $1.06 Million - $1.33 Million
-100,030 Reduced 3.12%
3,103,885 $36.9 Million
Q1 2022

May 11, 2022

SELL
$10.37 - $12.73 $780,031 - $957,550
-75,220 Reduced 2.29%
3,203,915 $37.4 Million
Q4 2021

Feb 10, 2022

SELL
$10.21 - $15.27 $3.39 Million - $5.07 Million
-332,150 Reduced 9.2%
3,279,135 $36.8 Million
Q3 2021

Nov 12, 2021

BUY
$14.07 - $17.3 $50.8 Million - $62.5 Million
3,611,285 New
3,611,285 $52.8 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.31B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.